Compositions and methods for treating IgE-mediated disorders
First Claim
Patent Images
1. An antibody comprising a heavy chain having SEQ ID NO:
- 42 and a light chain having SEQ ID NO;
40.
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to immunoglobulins that bind IgE and FcγRIIb with high affinity, said compositions being capable of inhibiting cells that express membrane-anchored IgE. Such compositions are useful for treating IgE-mediated disorders, including allergies and asthma.
-
Citations
3 Claims
-
1. An antibody comprising a heavy chain having SEQ ID NO:
- 42 and a light chain having SEQ ID NO;
40.
- 42 and a light chain having SEQ ID NO;
-
2. An isolated antibody comprising a heavy chain having having SEQ ID NO:
- 42 and a light chain having SEQ ID NO;
40.
- 42 and a light chain having SEQ ID NO;
-
3. A pharmaceutical composition comprising:
-
a) an antibody comprising a heavy chain having SEQ ID NO;
42 and a light chain having SEQ ID NO;
40; andb) a pharmaceutically acceptable carrier.
-
Specification